Miranda, Marissa C.
HRN: 22-07-18 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/24/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/24/2022
10/31/2022
IV
4.5g
Q8H
CAP-MR;PTB
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes